Customs Sequencing Markets
October 2011. The technological jump into next-generation sequencing brings considerable uncertainties to the business of custom sequencing, says Bruno Poddevin responsible for Eurofins' global genomic services. How can service providers cope with it? What exactly is the size of the market accessible to private companies today? How should daily operations take up opportunities? Is it an option to install laboratories in India or China to service customers in Europe or in the US? An estimate of market size, critical evaluation of segments and opportunities in different geographies for the next two to three years. About errors of the past and lessons learned: «Cobbler, stick to your trade» and what it means for the sequencing business.Reading time: 14 min
Read Now: |
Other articles recommended
B2Bioworld offers you background information
“We have some of the biggest databases in the world…”
Lab Automation: Everyone Re-invents the Wheel
Michael Collasius, Automated Systems Qiagen NV on sector industry-wide standards
Metrics for Health and Wellness
A systems look at DNA sequencing for personalized medicine by Leroy Hood, President Institute for Systems Biology, Seattle (US)
Shift in Cancer Research Translation
Christof von Kalle, at the time Head of Germany’s National Center for Tumor Diseases on new approaches to achieve tangible clinical results – or to manoeuvring into dead ends